The Rare Cancer Research Foundation (RCRF) has partnered with Spanios to advance the discovery and validation of groundbreaking therapeutic options for rare cancers. This partnership, facilitated through RCRF’s initiative, Pattern.org, marks a significant step towards addressing the pressing need for effective treatments in the realm of rare cancers.
 
Pattern.org, a patient-centric platform, empowers individuals battling rare cancers across the United States to donate fresh tumor tissue, irrespective of their treatment center, thereby driving forward scientific research.
 
Marshall Thompson, President of RCRF, emphasizes, “Connecting rare cancer patient sample donations with cutting-edge diagnostic and therapeutic researchers lies at the heart of RCRF’s mission. This partnership with Spanios will catalyze the discovery of new biomarkers and validate therapeutic approaches previously inaccessible to rare cancer patients.”
 
Vivek Ravi, Chief Executive Officer of Spanios, added, “We are excited to collaborate with the inspirational team at RCRF to advance therapeutic research for challenging cancer types, including rare and pediatric cancers. By combining our expertise, resources, and innovative platforms, we will deliver on our mission of identifying, discovering, and delivering effective treatments to the most underserved segments of our community.”